Collins, J. T., Nguyen, A. & Badireddy, M. Anatomy, Abdomen and Pelvis, Small Intestine (StatPearls, 2021).
Barrett, K. E. New ways of thinking about (and teaching about) intestinal epithelial function. Adv. Physiol. Educ. 32(1), 25–34 (2008).
Hamilton, I. et al. Small intestinal permeability in dermatological disease. Q. J. Med. 56(221), 559–567 (1985).
Harris, C. E. et al. Intestinal permeability in the critically ill. Intensive Care Med. 18(1), 38–41 (1992).
Ukabam, S. O., Mann, R. J. & Cooper, B. T. Small intestinal permeability to sugars in patients with atopic eczema. Br. J. Dermatol. 110(6), 649–652 (1984).
Wallaert, B. et al. Increased intestinal permeability in active pulmonary sarcoidosis. Am. Rev. Respir. Dis. 145(6), 1440–1445 (1992).
Han, X., Fink, M. P. & Delude, R. L. Proinflammatory cytokines cause NO*-dependent and -independent changes in expression and localization of tight junction proteins in intestinal epithelial cells. Shock 19(3), 229–237 (2003).
Yang, R. et al. IL-6 is essential for development of gut barrier dysfunction after hemorrhagic shock and resuscitation in mice. Am. J. Physiol. Gastrointest. Liver Physiol. 285(3), G621–G629 (2003).
Cao, M. et al. Amelioration of IFN-gamma and TNF-alpha-induced intestinal epithelial barrier dysfunction by berberine via suppression of MLCK-MLC phosphorylation signaling pathway. PLoS ONE 8(5), e61944 (2013).
Nahidi, L. et al. Differential effects of nutritional and non-nutritional therapies on intestinal barrier function in an in vitro model. J. Gastroenterol. 47(2), 107–117 (2012).
Smyth, D. et al. Interferon-gamma-induced increases in intestinal epithelial macromolecular permeability requires the Src kinase Fyn. Lab Invest. 91(5), 764–777 (2011).
Madara, J. L. & Stafford, J. Interferon-gamma directly affects barrier function of cultured intestinal epithelial monolayers. J. Clin. Invest. 83(2), 724–727 (1989).
Aschenbach, J. R. et al. Symposium review: The importance of the ruminal epithelial barrier for a healthy and productive cow. J. Dairy Sci. 102(2), 1866–1882 (2019).
Liang, D. et al. Estimating US dairy clinical disease costs with a stochastic simulation model. J. Dairy Sci. 100(2), 1472–1486 (2017).
Pascottini, O. B. et al. Effect of anti-inflammatory treatment on systemic inflammation, immune function, and endometrial health in postpartum dairy cows. Sci. Rep. 10(1), 5236 (2020).
Sanz-Fernandez, M. V. et al. Targeting the hindgut to improve health and performance in cattle. Animals (Basel) 10, 10 (2020).
Abuajamieh, M. et al. Inflammatory biomarkers are associated with ketosis in periparturient Holstein cows. Res. Vet. Sci. 109, 81–85 (2016).
Khafipour, E., Krause, D. O. & Plaizier, J. C. A grain-based subacute ruminal acidosis challenge causes translocation of lipopolysaccharide and triggers inflammation. J. Dairy Sci. 92(3), 1060–1070 (2009).
Koch, F. et al. Heat stress directly impairs gut integrity and recruits distinct immune cell populations into the bovine intestine. Proc. Natl. Acad. Sci. USA 116(21), 10333–10338 (2019).
Zhang, S. et al. Short-term feed restriction impairs the absorptive function of the reticulo-rumen and total tract barrier function in beef cattle. J. Anim. Sci. 91(4), 1685–1695 (2013).
Pate, R. T. et al. Immune and metabolic effects of rumen-protected methionine during a heat stress challenge in lactating Holstein cows. J. Anim. Sci. 99(12), 323 (2021).
Luissint, A. C., Parkos, C. A. & Nusrat, A. Inflammation and the intestinal barrier: Leukocyte-epithelial cell interactions, cell junction remodeling, and mucosal repair. Gastroenterology 151(4), 616–632 (2016).
van der Flier, L. G. & Clevers, H. Stem cells, self-renewal, and differentiation in the intestinal epithelium. Annu. Rev. Physiol. 71, 241–260 (2009).
Groschwitz, K. R. & Hogan, S. P. Intestinal barrier function: Molecular regulation and disease pathogenesis. J. Allergy Clin. Immunol. 124(1), 3–20 (2009) ((quiz 21-2)).
Vancamelbeke, M. & Vermeire, S. The intestinal barrier: A fundamental role in health and disease. Exp. Rev. Gastroenterol. Hepatol. 11(9), 821–834 (2017).
Pizarro, T. T. et al. IL-18, a novel immunoregulatory cytokine, is up-regulated in Crohn’s disease: Expression and localization in intestinal mucosal cells. J. Immunol. 162(11), 6829–6835 (1999).
Schroder, K. et al. Interferon-gamma: An overview of signals, mechanisms and functions. J. Leukoc. Biol. 75(2), 163–189 (2004).
Spriggs, D. R., Deutsch, S. & Kufe, D. W. Genomic structure, induction, and production of TNF-alpha. Immunol. Ser. 56, 3–34 (1992).
McNair, N. N. et al. Inflammasome components caspase-1 and adaptor protein apoptosis-associated speck-like proteins are important in resistance to Cryptosporidium parvum. Microbes Infect. 20(6), 369–375 (2018).
Siegmund, B. et al. Neutralization of interleukin-18 reduces severity in murine colitis and intestinal IFN-gamma and TNF-alpha production. Am. J. Physiol. Regul. Integr. Comp. Physiol. 281(4), R1264–R1273 (2001).
Nowarski, R. et al. Epithelial IL-18 equilibrium controls barrier function in colitis. Cell 163(6), 1444–1456 (2015).
Cui, L. et al. Changes in the blood routine, biochemical indexes and the pro-inflammatory cytokine expressions of peripheral leukocytes in postpartum dairy cows with metritis. BMC Vet. Res. 15(1), 157 (2019).
El-Deeb, W. M. & El-Bahr, S. M. Biomarkers of ketosis in dairy cows at postparturient period: Acute phase proteins and pro-inflammatory cytokines. Vet. Arhiv. 87(4), 431–440 (2017).
Zhao, C. et al. Inflammatory mechanism of Rumenitis in dairy cows with subacute ruminal acidosis. BMC Vet. Res. 14(1), 135 (2018).
Kasimanickam, R. K. et al. Associations among serum pro- and anti-inflammatory cytokines, metabolic mediators, body condition, and uterine disease in postpartum dairy cows. Reprod. Biol. Endocrinol. 11, 103 (2013).
Zachos, N. C. et al. Human enteroids/colonoids and intestinal organoids functionally recapitulate normal intestinal physiology and pathophysiology. J. Biol. Chem. 291(8), 3759–3766 (2016).
Derricott, H. et al. Developing a 3D intestinal epithelium model for livestock species. Cell Tissue Res. 375(2), 409–424 (2019).
Hamilton, C. A. et al. Development of in vitro enteroids derived from bovine small intestinal crypts. Vet. Res. 49(1), 54 (2018).
Rallabandi, H. R. et al. Evaluation of intestinal epithelial barrier function in inflammatory bowel diseases using murine intestinal organoids. Tissue Eng. Regen. Med. 17(5), 641–650 (2020).
Xu, P. et al. Intestinal organoid culture model is a valuable system to study epithelial barrier function in IBD. Gut 67(10), 1905–1906 (2018).
Crakes, K. R. et al. Fenofibrate promotes PPARalpha-targeted recovery of the intestinal epithelial barrier at the host-microbe interface in dogs with diabetes mellitus. Sci. Rep. 11(1), 13454 (2021).
Armien, A. G. et al. Molecular and biological characterization of a cervidpoxvirus isolated from moose with necrotizing dermatitis. Vet. Pathol. 57(2), 296–310 (2020).
Farquhar, M. G. & Palade, G. E. Junctional complexes in various epithelia. J. Cell Biol. 17, 375–412 (1963).
Gonschior, H. V., Haucke, & Lehmann, M. Super-resolution imaging of tight and adherens junctions: Challenges and open questions. Int. J. Mol. Sci. 21, 3 (2020).
Perez-Bosque, A. et al. Dietary intervention with serum-derived bovine immunoglobulins protects barrier function in a mouse model of colitis. Am. J. Physiol. Gastrointest. Liver Physiol. 308(12), G1012–G1018 (2015).
Kaplanski, G. Interleukin-18: Biological properties and role in disease pathogenesis. Immunol. Rev. 281(1), 138–153 (2018).
Bardenbacher, M. et al. Permeability analyses and three dimensional imaging of interferon gamma-induced barrier disintegration in intestinal organoids. Stem Cell Res. 35, 101383 (2019).
Onozato, D. et al. Application of human induced pluripotent stem cell-derived intestinal organoids as a model of epithelial damage and fibrosis in inflammatory bowel disease. Biol. Pharm. Bull. 43(7), 1088–1095 (2020).
Blum, M. S. et al. Cytoskeletal rearrangement mediates human microvascular endothelial tight junction modulation by cytokines. Am. J. Physiol. 273(1 Pt 2), H286–H294 (1997).
Gitter, A. H. et al. Epithelial barrier defects in HT-29/B6 colonic cell monolayers induced by tumor necrosis factor-alpha. Ann. N. Y. Acad. Sci. 915, 193–203 (2000).
McKay, D. M. & Singh, P. K. Superantigen activation of immune cells evokes epithelial (T84) transport and barrier abnormalities via IFN-gamma and TNF alpha: Inhibition of increased permeability, but not diminished secretory responses by TGF-beta2. J. Immunol. 159(5), 2382–2390 (1997).
Mullin, J. M. & Snock, K. V. Effect of tumor necrosis factor on epithelial tight junctions and transepithelial permeability. Cancer Res. 50(7), 2172–2176 (1990).
Rodriguez, P. et al. Tumour necrosis factor-alpha induces morphological and functional alterations of intestinal HT29 cl.19A cell monolayers. Cytokine 7(5), 441–448 (1995).
Youakim, A. & Ahdieh, M. Interferon-gamma decreases barrier function in T84 cells by reducing ZO-1 levels and disrupting apical actin. Am. J. Physiol. 276(5), G1279–G1288 (1999).
Al-Sadi, R., Boivin, M. & Ma, T. Mechanism of cytokine modulation of epithelial tight junction barrier. Front. Biosci. (Landmark Ed.) 14(7), 2765–2778 (2009).
Madara, J. L. Regulation of the movement of solutes across tight junctions. Annu. Rev. Physiol. 60, 143–159 (1998).
Wang, X. et al. Exploring tight junction alteration using double fluorescent probe combination of lanthanide complex with gold nanoclusters. Sci. Rep. 6, 32218 (2016).
Butkevych, E. et al. Contribution of epithelial apoptosis and subepithelial immune responses in Campylobacter jejuni-induced barrier disruption. Front. Microbiol. 11, 344 (2020).
Thaiss, C. A. et al. Hyperglycemia drives intestinal barrier dysfunction and risk for enteric infection. Science 359(6382), 1376–1383 (2018).
Lu, C.-H. et al. Apical Actin-Myosin Network Regulates the Tight Junction of Polarized Madin-Darby Canine Kidney Cells. bioRxiv (2021).
Maloy, K. J. & Powrie, F. Intestinal homeostasis and its breakdown in inflammatory bowel disease. Nature 474(7351), 298–306 (2011).
Croitoru, K. & Zhou, P. T-cell-induced mucosal damage in the intestine. Curr. Opin. Gastroenterol. 20(6), 581–586 (2004).
Ramachandran, A., Madesh, M. & Balasubramanian, K. A. Apoptosis in the intestinal epithelium: Its relevance in normal and pathophysiological conditions. J. Gastroenterol. Hepatol. 15(2), 109–120 (2000).
Croinin, T. O. & Backert, S. Host epithelial cell invasion by Campylobacter jejuni: Trigger or zipper mechanism?. Front. Cell Infect. Microbiol. 2, 25 (2012).
Gunzel, D. et al. Restitution of single-cell defects in the mouse colon epithelium differs from that of cultured cells. Am. J. Physiol. Regul. Integr. Comp. Physiol. 290(6), R1496–R1507 (2006).
Grabinger, T. et al. Ex vivo culture of intestinal crypt organoids as a model system for assessing cell death induction in intestinal epithelial cells and enteropathy. Cell Death Dis. 5, e1228 (2014).
Kanai, T. et al. Interleukin 18 is a potent proliferative factor for intestinal mucosal lymphocytes in Crohn’s disease. Gastroenterology 119(6), 1514–1523 (2000).
Nakamura, S. et al. Expression and responsiveness of human interleukin-18 receptor (IL-18R) on hematopoietic cell lines. Leukemia 14(6), 1052–1059 (2000).
Workman, M. J. et al. Modeling intestinal epithelial response to interferon-gamma in induced pluripotent stem cell-derived human intestinal organoids. Int. J. Mol. Sci. 22(1), 288 (2020).